BSE filing, NSE: SAREGAMA. Summary written from the filing by ALFA Finder's alert engine.
Saregama India Ltd: key numbers
- Share price
- ₹643.50
- Market cap
- ₹12,407 Cr
- Revenue (annual)
- ₹984.6 Cr
- Net profit (annual)
- ₹207.1 Cr
- P/E (TTM)
- 51.4×Sector 27.7×
- Promoter holding
- 60.84%+0.00% QoQ
- FII holding
- 11.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saregama India Ltd
All →Saregama India Earnings Call Transcript: Key Takeaways
Q2 revenue ₹314 Cr (+37%) and adj. EBITDA ₹118 Cr (+39%), helped by a low base and upfront recognition of old-film licensing. Management pushes a rolling-12-month view.
- Call
- Guides 20% growth
Saregama India Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 3,143 Mn (+37% YoY), Adj. EBITDA INR 1,180 Mn (+39%), PAT INR 642 Mn (+47%). Music-led growth; Live Events doubled; Video down 16%.
Saregama India Q2 FY27 Results: Net Profit ₹64.2 Cr, Up 46.6% YoY
Saregama India Ltd reported revenue from operations of ₹314.3 Cr (+36.7% YoY) and net profit of ₹64.2 Cr (+46.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹64.2 Cr · +46.6% YoY
Saregama India Other Announcement
Saregama India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure reports the current stake distribution among its shareholders.
Saregama India Employee Stock Options
Saregama India approved the grant of 10,50,000 employee stock options to an eligible employee at an exercise price of Rs. 496.70 per share.
Saregama India Annual General Meeting
Saregama India held its 79th AGM on September 15, 2026, via video conferencing. The meeting covered routine business, including the adoption of financial statements and audit resolutions.
Other merger & restructuring announcements
All →Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr
Jindal Poly Films Merger & Restructuring
Jindal Poly Films' step-down subsidiary, JPF API Laminates UK Limited, was dissolved effective November 3, 2026. It has ceased to be a subsidiary of the company.
Clean Max Enviro Energy Solutions Merger & Restructuring Worth ₹2.1 Cr
Clean Max Enviro will incorporate a wholly owned IFSC subsidiary for Global Treasury Centre activities. It will subscribe 21,00,000 shares for ₹2.10 Crore in cash.
- Value
- ₹2.10 Cr